These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 11294398)

  • 21. Ligands of the histamine H3-receptor: new potent antagonists of the 2-thioimidazole type.
    Plazzi PV; Mor M; Bordi F; Silva C; Rivara S; Caretta A; Ballabeni V; Impicciatore M; Vitali T
    Farmaco; 1997 May; 52(5):295-302. PubMed ID: 9274000
    [TBL] [Abstract][Full Text] [Related]  

  • 22. omega-(Imidazol-4-yl)alkane-1-sulfonamides: a new series of potent histamine H(3) receptor antagonists.
    Tozer MJ; Buck IM; Cooke T; Kalindjian SB; Pether MJ; Steel KI
    Bioorg Med Chem; 2002 Feb; 10(2):425-32. PubMed ID: 11741790
    [TBL] [Abstract][Full Text] [Related]  

  • 23. 2-(4-alkylpiperazin-1-yl)quinolines as a new class of imidazole-free histamine H3 receptor antagonists.
    Zaragoza F; Stephensen H; Peschke B; Rimvall K
    J Med Chem; 2005 Jan; 48(1):306-11. PubMed ID: 15634025
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Novel nonimidazole histamine H3 receptor antagonists: 1-(4-(phenoxymethyl)benzyl)piperidines and related compounds.
    Mikó T; Ligneau X; Pertz HH; Ganellin CR; Arrang JM; Schwartz JC; Schunack W; Stark H
    J Med Chem; 2003 Apr; 46(8):1523-30. PubMed ID: 12672253
    [TBL] [Abstract][Full Text] [Related]  

  • 25. 4-[(1H-imidazol-4-yl) methyl] benzamidines and benzylamidines: novel antagonists of the histamine H3 receptor.
    Aslanian R; Brown JE; Shih NY; wa Mutahi M; Green MJ; She S; Del Prado M; West R; Hey J
    Bioorg Med Chem Lett; 1998 Aug; 8(16):2263-8. PubMed ID: 9873525
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Investigation of the histamine H3 receptor binding site. Design and synthesis of hybrid agonists with a lipophilic side chain.
    Ishikawa M; Watanabe T; Kudo T; Yokoyama F; Yamauchi M; Kato K; Kakui N; Sato Y
    J Med Chem; 2010 Sep; 53(17):6445-56. PubMed ID: 20690643
    [TBL] [Abstract][Full Text] [Related]  

  • 27. 4-Alkynylphenyl imidazolylpropyl ethers as selective histamine H3-receptor antagonists with high oral central nervous system activity.
    Krause M; Ligneau X; Stark H; Garbarg M; Schwartz JC; Schunack W
    J Med Chem; 1998 Oct; 41(21):4171-6. PubMed ID: 9767653
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Development of a pharmacophore model for histamine H3 receptor antagonists, using the newly developed molecular modeling program SLATE.
    De Esch IJ; Mills JE; Perkins TD; Romeo G; Hoffmann M; Wieland K; Leurs R; Menge WM; Nederkoorn PH; Dean PM; Timmerman H
    J Med Chem; 2001 May; 44(11):1666-74. PubMed ID: 11356102
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A scalable synthesis of a histamine H3 receptor antagonist.
    Mani NS; Jablonowski JA; Jones TK
    J Org Chem; 2004 Nov; 69(23):8115-7. PubMed ID: 15527300
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Convenient procedures for synthesis of ciproxifan, a histamine H3-receptor antagonist.
    Stark H
    Arch Pharm (Weinheim); 2000 Sep; 333(9):315-6. PubMed ID: 11039189
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Validation of a histamine H3 receptor model through structure-activity relationships for classical H3 antagonists.
    Lorenzi S; Mor M; Bordi F; Rivara S; Rivara M; Morini G; Bertoni S; Ballabeni V; Barocelli E; Plazzi PV
    Bioorg Med Chem; 2005 Oct; 13(19):5647-57. PubMed ID: 16085419
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Synthesis and biological assays of new H3-antagonists with imidazole and imidazoline polar groups.
    Mor M; Bordi F; Silva C; Rivara S; Zuliani V; Vacondio F; Morini G; Barocelli E; Ballabeni V; Impicciatore M; Plazzi PV
    Farmaco; 2000 Jan; 55(1):27-34. PubMed ID: 10755228
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Importance of the lipophilic group in carbamates having histamine H3-receptor antagonist activity.
    Kieć-Kononowicz K; Wiecek M; Sasse A; Ligneau X; Elz S; Ganellin CR; Schwartz JC; Stark H; Schunack W
    Pharmazie; 2000 May; 55(5):349-55. PubMed ID: 11828613
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Imidazole H3-antagonists: relationship between structure and ex vivo binding to rat brain H3-receptors.
    Vacondio F; Mor M; Silva C; Zuliani V; Rivara M; Rivara S; Bordi F; Plazzi PV; Magnanini F; Bertoni S; Ballabeni V; Barocelli E; Carrupt PA; Testa B
    Eur J Pharm Sci; 2004 Sep; 23(1):89-98. PubMed ID: 15324926
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Ether derivatives of 3-piperidinopropan-1-ol as non-imidazole histamine H3 receptor antagonists.
    Łazewska D; Ligneau X; Schwartz JC; Schunack W; Stark H; Kieć-Kononowicz K
    Bioorg Med Chem; 2006 May; 14(10):3522-9. PubMed ID: 16466921
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Characterization of histamine H3 receptors in mouse brain using the H3 antagonist [125I]iodophenpropit.
    Jansen FP; Mochizuki T; Maeyama K; Leurs R; Timmerman H
    Naunyn Schmiedebergs Arch Pharmacol; 2000 Jul; 362(1):60-7. PubMed ID: 10935534
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Synthesis and biological evaluation of diamine-based histamine H3 antagonists with serotonin reuptake inhibitor activity.
    Stocking EM; Miller JM; Barbier AJ; Wilson SJ; Boggs JD; McAllister HM; Wu J; Lovenberg TW; Carruthers NI; Wolin RL
    Bioorg Med Chem Lett; 2007 Jun; 17(11):3130-5. PubMed ID: 17412583
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Design, synthesis, and structure-activity relationships of acetylene-based histamine H3 receptor antagonists.
    Ali SM; Tedford CE; Gregory R; Handley MK; Yates SL; Hirth WW; Phillips JG
    J Med Chem; 1999 Mar; 42(5):903-9. PubMed ID: 10072687
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Medicinal chemistry and biological properties of non-imidazole histamine H3 antagonists.
    Cowart M; Altenbach R; Black L; Faghih R; Zhao C; Hancock AA
    Mini Rev Med Chem; 2004 Nov; 4(9):979-92. PubMed ID: 15544558
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Furoxan analogues of the histamine H3-receptor antagonist imoproxifan and related furazan derivatives.
    Tosco P; Bertinaria M; Di Stilo A; Cena C; Sorba G; Fruttero R; Gasco A
    Bioorg Med Chem; 2005 Aug; 13(15):4750-9. PubMed ID: 15946850
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.